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Hand, foot and mouth disease (HFMD) is a prevalent contagious childhood disease typically associated 
with fever, oral lesions and limb exanthema. While HFMD is caused by a plethora of serotypes of 
viruses under the genus Enterovirus within the Picornaviridae family, Coxsackievirus A16 (CV-A16) and 
Enterovirus 71 (EV-A71) are considered the main etiological agents. In recent years however, other 
viruses have also been isolated in considerable numbers from infected individuals in many regions, 
joining the legion commonly associated with HFMD. The present study investigated the cytokine and 
chemokine profiles of HFMD patients from Singapore and Malaysia for the first time. Comparative 
cohort studies of EV-A71-associated HFMD cases revealed that the Malaysia cohort had a distinct 
profile from the Singapore cohort, and this could be partly attributed by different EV-A71 genotypes. 
As the isolation of CV-A6, instead of CV-A16, had become prevalent in the Singapore cohort, it was 
also of particular interest to study the differential cytokine and chemokine profiles. Our data revealed 
that overlapping as well as unique profiles exist between the two major causative clinical isolates in 
the Singapore cohort. Having a better understanding of the respective immunological profiles could 
be useful for more accurate HFMD diagnosis, which is imperative for disease transmission control until 
multi-valent vaccines and/or broad-spectrum anti-viral drugs become available.
Hand, foot and mouth disease (HFMD) is a widespread transmissible infectious disease caused by a myriad of eti-
ological agents under the genus Enterovirus within the Picornaviridae family, with Coxsackievirus A16 (CV-A16) 
and Enterovirus A71 (EV-A71) generally regarded as its major causative agents1. CV-A16 is regarded as the most 
dominant serotype that causes asymptomatic or mild HFMD which resolves on its own most of the time. EV-A71, 
on the other hand, is a neurotropic virus associated with neurological complications and even deaths in infants 
and children in the Asia Pacific region2–7. Due to its virulence, EV-A71 causes a raising concern in the otherwise 
generally mild and self-limiting disease. Over the past two decades, tremendous research has been done to com-
pare these two key players.
In addition to CV-A16 and EV-A71, other serotypes such as CV-A4, CV-A5, CV-A6, CV-A7, CV-A9, 
CV-A10, CV-A24, Coxsackievirus B2 (CV-B2), CV-B3, CV-B4, CV-B5, EV-G18, EV-D70 and Echovirus 7 (E-7) 
are also known to cause HFMD albeit in smaller numbers3,8. Some of these serotypes, however, are becoming 
more prevalent in the recent years, being capable of existing as the main circulating virus of HFMD outbreaks in 
some regions.
In particular, CV-A6 is an emerging HFMD-causing virus strain capable of causing outbreaks in many 
regions9–18. In the recent years, the two predominant strains causing HFMD outbreaks in Singapore have also 
shifted from the conventional CV-A16 and EV-A71 to CV-A6 and EV-A7119–23. Similar to CV-A16, CV-A6 
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infections are usually self-limiting unlike neurotrophic EV-A71 infections. However, CV-A6 infections are 
reportedly associated with atypical clinical presentations including onychomadesis9–11,14,15, eczema herpeticum17, 
skin rashes and/or eruptions at unusual sites14,18, varicella-like skin eruptions18, allergic dermatitis-like rashes12 
and desquamation of palms and soles10,14,18. As the paradigm changes, it is imperative that a better understanding 
of CV-A6, the emerging HFMD causative agent, is achieved.
This study was aimed at analysing the cytokine and chemokine profiles of HFMD patients from Singapore 
and Malaysia. Cytokines are a group of small secretory signalling molecules with diverse immune-related roles24. 
Chemokines are a subclass of cytokines which have chemotactic properties25. Several independent studies had 
previously shown an association between elevated inflammatory cytokines and HFMD pathogenesis and progres-
sion26–39. However, none of these studies has examined HFMD cases from Singapore and Malaysia. In addition, 
previous studies have not analysed HFMD cases associated with CV-A6 infections, which was addressed in the 
present study.
Results and Discussion
The recruited HFMD study cohort was screened for its viral etiology and the individuals were grouped according 
to the causative etiological agents that they were infected with. There were a total of 2 CV-A16-infected patients, 
11 EV-A71-infected patients, 10 CV-A6-infected patients, and 9 healthy volunteers enrolled for the Singapore 
cohort, as well as 1 CV-A16-infected patient, 34 EV-A71-infected patients, and 1 CV-A6-infected patient enrolled 
for the Malaysia cohort. Since this study involved children of young age, it was difficult to obtain parental consent 
and voluntary compliance in the collection of sera from the HFMD patients and healthy children in Singapore/
Malaysia’s context. Hence, we were unable to enrol a large cohort for our studies.
While EV-A71 remained as the major serotype isolated in both the Singapore and Malaysia cohorts, we 
observed a paradigmatic shift towards the CV-A6 serotype in the more recent recruitment from Singapore. On 
the contrary, the supposedly common CV-A16 serotype was rarely isolated in both our study cohorts. Several 
studies also reported similar epidemiological trends40.
In this retrospective study, we focused on evaluating the cytokine and chemokine responses of 
EV-A71-associated HFMD cases between the Singapore and Malaysia cohort. In addition, we also explored the 
cytokine and chemokine responses of HFMD patients infected by EV-A71 and CV-A6 from Singapore. To our 
knowledge, cytokine and chemokine profiling has not been done in CV-A6-associated HFMD cases, which is 
of our interest to its recent predominance in Singapore. The fine-tuning of the levels of myriad cytokines and 
chemokines, which are crucial immune modulators, upon viral infection determines an anti-viral state advan-
tageous to the hosts or a pro-viral state advantageous to the invading viruses. Hence, evaluation of the cytokines 
and chemokines would provide insights to the dynamics of HFMD disease development depending on the causa-
tive agents implicated. We profiled the HFMD and healthy control sera for an array of 48 cytokines and chemok-
ines and compared the levels across the different serotypes (Supplementary Table S1). CV-A16-infected patients 
from both cohorts and CV-A6-infected patients from the Malaysia cohort were excluded from the comparative 
analyses as the extremely small sample size is not a true representative of the respective serotypes.
The heat map shown in Fig. 1 revealed two distinctive clusters representing HFMD patients from the two 
different cohorts, implying dissimilarities in the dysregulation of cytokines/chemokines between the Singapore 
and Malaysia cohorts.
Figure 1. Heat map comparing the sera cytokine and chemokine expression profiles of HFMD patients 
revealed two distinctive clusters representing HFMD patients from Singapore and Malaysia respectively.
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EV-A71 serotypes were compared between the two cohorts, and Mann-Whitney non-parametric tests con-
firmed statistically significant differences between the two cohorts in 39 out of the panel of 48 cytokines and 
chemokines assayed (Fig. 2).
Since the Malaysia cohort was recruited in 2000 and 2012 while the Singapore cohort was recruited between 
2013 and 2014, we speculated that the circulating EV-A71 (the major serotype isolated) genotype might 
be a contributing factor to the differences observed. To address this, comparisons were made between the 
EV-A71-infected patients recruited in 2000 and those recruited in 2012, where the main circulating EV-A71 
genotypes were B4/C5 and B5 respectively41. Mann-Whitney non-parametric tests showed that 13 out of 48 
cytokines were statistically different between the two periods of recruitment, where the HFMD patients from 
2000 had higher sera levels of these cytokines/chemokines except for CTACK (Supplementary Figure S2). This 
might suggest that different EV-A71 genotypes could trigger host immune responses in different magnitudes, 
thereby emphasising a need to consider the circulating genotype when studying cytokine/chemokine dysregula-
tion in EV-A71-associated HFMD.
Previous profiling studies mainly explored HFMD or HFMD of different severities in EV-A71- and/or 
CV-A16- infected patients26–39. Since CV-A6-associated HFMD cases were becoming more prevalent in the 
Singapore cohort, we were particularly interested in its differential cytokine/chemokine dysregulation in com-
parison to EV-A71-associated HFMD cases since this area had not been explored. A comparative analysis was 
performed between EV-A71- and CV-A6-associated HFMD cases in the Singapore cohort, using healthy control 
sera as a reference (Fig. 3).
Interestingly, EV-A71 and CV-A6 shared a large number of cytokines/chemokines dysregulation: EV-A71 
and CV-A6-infected HFMD patients had significantly reduced levels of sera IL-1α, MIF, IL-1β, IL-2, IL-8, IL-15, 
FGF-basic, GM-CSF, MCP-1, MIP-1α, and MIP-1β as well as increased levels of sera IL-16, IL-18, CTACK, 
β-NGF, SDF-1α, IL-5, IL-7, IL-13, IP-10, and PDGF-ββ. In addition to the large set of commonly dysregulated 
Figure 2. The expression profiles of EV-A71-infected patients from Singapore and Malaysia showed 
significant differences in 39 out of the panel of 48 cytokines and chemokines assayed. The statistical analyses 
were performed using GraphPad Prism version 4.0 (GraphPad software, USA), using Mann-Whitney 
non-parametric tests (without Gaussian distribution assumption). *p value < 0.05, **p value < 0.01, ***p 
value < 0.001. KK Enterovirus refers to EV-A71 cases from Singapore cohort, while UM Enterovirus refers to 
EV-A71 cases from Malaysia cohort.
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cytokines and chemokines, the two disease serotypes had their own subset of cytokine and chemokine dysreg-
ulation. EV-A71-associated HFMD cases displayed depressed expression of IL12p40, MCP-3, M-CSF, and IL-9 
as well as augmented eotaxin. CV-A6-associated HFMD cases showed increased expression of IL-2Rα, GRO-α, 
IFN-α2, TRAIL, IL-1Rα, IL-10, and TNF-α.
Indeed, previous studies also presented HFMD cases of decreased levels of MIF, IL-8, MIP-1β, and M-CSF29, 
as well as increased levels of IL-1842, IL-536, IP-1042–44, and eotaxin29. In addition, EV-A71 cases of increased levels 
of IL-1832 and IL-1333 have also been reported. Hence, these cytokines probably present generic cytokines impli-
cated in HFMD cases. Some of the cytokines/chemokines including IL-832, GM-CSF30, MCP-142,44, IL-12p4029, 
and MCP-329 were found to be dysregulated in opposite trends in other studies, thereby emphasising possible 
functional redundancies.
MIF, a pro-inflammatory cytokine of the immune system, is associated with disease severity and poor disease 
outcome45. Since HFMD is generally a mild and self-limiting disease and the patients from the Singapore cohort 
suffered from uncomplicated HFMD with full recoveries, MIF was expectedly decreased in most of them. IL-7 has 
also been reported to inhibit immunosuppressive Socs3 protein responsible for chronic virus infections46, possi-
bly a key factor for a generally self-limiting disease. Cook et al. (1995) demonstrated that coxsackievirus-infected 
homozygous MIP-1α mutant mice suffered from less severe pneumonitis and were protected from virus-induced 
myocarditis even though there was delayed virus clearance in comparison to infected wildtypes47. Since MIP-1β 
shared 67% sequence identity with MIP-1α48, it was speculated that down-regulation of MIP-1β was also a 
measure to avert disease progression. IP-10 augmentation was not surprising since it was shown to inhibit CB3 
viral replication49. MCP-3 has also been shown to inhibit viral replication as part of the anti-viral host defense 
Figure 3. The cytokine and chemokine expression profiles of HFMD patients from Singapore showed 
significant differences between the two major etiological agents they were infected with. The statistical 
analyses were performed using GraphPad Prism version 4.0 (GraphPad software, USA), using Kruskal-Wallis 
non-parametric test (without Gaussian distribution assumption) coupled with Dunns post-test. All p-values 
were automatically adjusted by the program to account for false discovery rates associated with multiple 
comparisons. *p value < 0.05, **p value < 0.01, ***p value < 0.001. All p values stated were referenced to the 
healthy cohort, unless otherwise indicated by lines. Healthy refers to healthy volunteers, KKH_CA6 refers to 
CV-A6 cases, and KKH_EV71 refers to EV-A71 cases from Singapore cohort.
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mechanism50. M-CSF, shown to suppress CVB3 virus infection, reduce disease severity, and improve survival51, 
was reduced in EV-A71-associated HFMD cases.
IL-2 and GM-CSF were reduced perhaps to subvert host immunity. A recent publication by Felix et al. (2016) 
proposed the concept of virus-induced molecular mimicries in antagonising host-induced anti-viral cytokines 
(such as IL-2 and GM-CSF)52. The phenomenon of IL-8 reduction was not surprising as Dodd et al. (2001) 
showed how poliovirus, which belongs to the same family as enteroviruses, could limit IL-8 secretion during 
infection53. IL-15, a key regulator of anti-viral response during innate immunity54, was suppressed probably in 
the favor of the viruses. IL-9, reported to inhibit viral replication in CVB3-induced myocarditis55, was suppressed 
as well. IL-1Rα enhancement was also shown to be a virus’ evasion strategy56,57. FGF basic, which was reported 
to induce local infection to promote the healing process58, was significantly diminished. This might explain the 
higher probability of complications in EV-A71 infections2–7, as well as more persistency in the generally mild 
CV-A6 infections59 causing consequences such as onychomadesis as late onset manifestations. IL-16 was demon-
strated to retard virus spread and control virus propagation60, and this could account for the late onset manifes-
tations in the generally mild CV-A6 infections. TRAIL61 and IL-1062 has both pro- and anti-viral roles, hence it is 
unclear which role it serves in CV-A6-associated HFMD.
The suppression of IL-2, a Th1 cytokine, might possibly be a virus strategy to counter IL-2Rα increment. 
Indeed, IL-12, which is responsible for the induction of Th1 cytokines, was also diminished. IL-12 induction of 
Th1 cytokines was reported to be vital for anti-viral immunity and virus clearance63,64. These supported previous 
studies which reported implications of skewed Th2 cytokine response resembling the pathophysiology of allergic 
diseases in HFMD patients. The authors reasoned that the Th2-biased responses could be the fatal trigger for res-
piratory dysfunctions and failure32 or indicator of poor prognosis with higher fever and longer illness duration65.
Indeed, many cytokines and chemokines involved in a Th2 response or implicated in allergic diseases were 
dysregulated. IL-18, an imperative contributor of the generation of cytotoxic T lymphocytes against invading 
viruses66, was reported to be able to skew towards a Th2 response in the absence of IL-12 and IL-1567. β-NGF, 
produced by effector cells of allergic diseases, was amplified in HFMD patients as in allergic diseases such as 
asthma68,69 and allergic dermatitis70,71. SDF-1α, another factor implicated in chronic inflammatory skin diseases72 
and asthma73, could also explain previous publications on HFMD similarity to allergic diseases. IL-5 is a pleio-
tropic Th2 cytokine commonly associated to asthma pathogenesis74. IL-13, also a Th2 cytokine, was implicated 
as an important contributor to virus-induced acute airway hyper-responsiveness and inflammation leading 
to asthma75. IL-7 was reported as a plausible contributor to airway inflammation in asthmatics76. Eotaxin, an 
eosinophil chemoattractant, was implicated in virus-induced airway inflammatory processes and disease exac-
erbations77–80. MCP-1, however, was surprisingly decreased since its augmentation was also previously linked 
to Th2 polarisation81. C-TACK, a predominantly cutaneous T cell selective chemokine82, was up-regulated. A 
skin-specific immune response was anticipated since HFMD is enanthematous and exanthematous in nature.
IFN-α2 and TNF-α have pyrogenic roles which may contribute to the febrile response commonly observed 
in patients with HFMD83,84. However the supposedly most potent endogenous pyrogens – IL-1α and IL-1β85 – 
were oddly diminished. Dinarello (2004) reported that infection-associated fever could be induced independent 
of pyrogenic cytokines (such as IL-1 and TNF) via TLR86. Another speculation was the virus’ strategy to regulate 
host temperature changes in order to persist in the host without much deterrence. Indeed, virus-shedding studies 
by Li et al.87 and Zhao et al.88 revealed EV-A71 could persist in the body for weeks even after the disease symp-
toms had subsided.
PDGF-BB induces proliferation through MAPK, JAK/STAT and PI3K pathways89. Wu et al. (2016) reported 
a positive correlation between cell proliferation and EV-A71 infection through a genome-wide RNAi screen, and 
revealed that many top hits were involved in cell proliferation or growth factor signalling pathways90.
In summary, it should be stressed that interpreting the overall outcome of the dynamic fluctuations of 
cytokine/chemokine cascade, instead of monitoring specific cytokine/chemokine alterations, would be more 
insightful to understanding the disease due to the functional redundancies of cytokines and chemokines91. This 
could also explain the irreproducibility of cytokine/chemokine dysregulation implicated in HFMD across dif-
ferent publications26–39. Our study also showed that the different cytokine/chemokine dysregulation triggered 
by EV-A71- and CV-A6-associated HFMD seemed to result in a similar clinical outcome. These observations 
could perhaps reflect the virus’ versatility in eliciting the same outcome through different channels. Hence, it is 
important to take into account the overall outcome(s) of the different combination of cytokine/chemokine dys-
regulation rather than a particular (set of) cytokine/chemokine dysregulation as disease biomarkers. From this 
study, it seemed that the viruses were striking an astute balance between exploitation of the host machinery for 
invasion and aversion of the host immunity for evasion.
First, we found that the dysregulation was seemingly triggered by the viruses in order to attain a balanced 
control of the host immune responses. In order for viruses to invade and propagate within the host, viruses need 
to modulate the host immune system such that they can take dominance over the host yet avoid over-stimulating 
the host immune system which will result in death. As such, viruses have to be able to strike a delicate balance 
to co-exist with and persist in the host, fighting off host anti-viral responses and restraining its invasion simulta-
neously. Next, a skewed Th2 response mirroring allergic diseases was presumably an attempt to avoid anti-viral 
immunity and virus clearance by Th1 cytokines63,64. In addition, the enanthematous and exanthematous nature 
of HFMD would naturally beget a skin-specific immune response. Since HFMD is a febrile illness, pyrogenic 
cytokines were also anticipated to be implicated. However, it was not surprising that cytokine-independent 
pyretic factors could still result in fever86. Lastly, an active cell mitotic status (G2/M phase of cell cycle) was pos-
tulated to promote viral replication in the proliferating cells. Moreover, mitotic progression could also initiate a 
switch from cap-dependent translation to internal-ribosome site-dependent translation necessary for enterovirus 
translation processes90.
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While independent reports of EV-A71-induced ‘cytokine storm’, which describes a persistently over-stimulated 
immune response as a result of a positive feedback loop between cytokines and immune cells92,93, have been 
documented previously37,94–96, our study showed that the augmented cytokines in EV-A71-infected patients 
were also up-regulated in CV-A6-infected patients with the exception of eotaxin. Instead, EV-A71-infected 
patients had decreased sera levels of a subset of cytokines/chemokines not found to be significantly dysregulated 
in CV-A6-infected patients. In addition, CV-A6-infected patients had increased sera levels of another subset 
of cytokines/chemokines not found to be significantly dysregulated in EV-A71-infected patients. As previous 
studies have not explored CV-A6-associated cytokine/chemokine dysregulation, this pilot study showed for the 
first time the dynamics of this emerging HFMD causative agent in the host. Although CV-A6 usually causes 
self-limiting infections unlike neurotrophic EV-A71, its persistence causing consequences such as onychomadesis 
as late onset manifestations remained puzzling. These findings showed that CV-A6 is capable of eliciting greater 
(or at least the same) cytokine/chemokine dysregulation than (as) EV-A71, thereby highlighting a need to explore 
serotype-specific cytokine/chemokine dysregulation in HFMD patients to understand the clinical presentations 
associated with the respective etiological agents.
For example, onychomadesis was reported in young children who did not receive treatment from autosomal 
recessive loss-of-function mutations in IL1RN gene resulting in IL-1Ra deficiency. Interestingly, CV-A6-infected 
patients were found to have diminished levels of IL-1α and IL-1β as well as augmented levels of IL-1Ra97. 
Since onychomadesis is a late onset manifestation observed in CV-A6-associated HFMD cases, it was specu-
lated that the over-compensation of cytokine/chemokine dysregulation might have triggered this. Other than 
CV-A6-associated HFMD, patients recovering from toxic shock syndrome also experienced desquamation one 
to three weeks after onset as well as nail shedding and Beau’s lines after recovery98. Cytokines such as TNF-α, 
IL-1, IL-6, IL-2, and IFN-γ were amplified in these patients. The expression of TNF-α was also increased in 
CV-A6-infected patients. Psoriasis lesions were found to have increased levels of cytokines including TNF-α and 
decreased levels of cytokines including IL-1 and IL-10. However, Saulite and colleagues found augmented IL-10 
in psoriasis-affected nail beds, suggesting that IL-10 could specifically be linked to nail changes99. Coincidentally, 
IL-10 was also exhibited at high levels in CV-A6-associated HFMD cases. It would be interesting to study the 
implications of differential cytokine/chemokine dysregulation between EV-A71 and CV-A6 by exploring the 
influence(s) of these cytokines and/or chemokines on the pathogenesis of the two viruses.
Despite a small sample size, this is the first study on the cytokine/chemokine profiles of the HFMD patients 
from the Singapore and Malaysia cohort. In particular, we showed that the Singapore and Malaysia cohorts had 
differential cytokine/chemokine dysregulation, even when infected with the same causative serotype (i.e. EV-A71). 
Further analyses showed that differences were observed even when comparison was made between different peri-
ods of recruitment within the same cohort. This showed that causative EV-A71 genotype played a contributing role 
in the differential dysregulation. Comparative analyses between the two major causative serotypes isolated from the 
Singapore cohort showed that causative serotype played a contributing role in the differential dysregulation as well. 
We showed for the first time the similarity and dissimilarity in the cytokine/chemokine dysregulation between 
EV-A71- and CV-A6-infected HFMD patients. As samples were obtained from consented patients upon hospital-
isation, it was not possible to pre-determine the stage of infection the patients were in during sample collection. 
Hence, the differential profiles could also be partly influenced by the different stages of infection. Nevertheless, 
we hypothesised that the viruses were capable of flexible fine-tuning of the plethora of cytokines/chemokines 
towards a similar outcome. Further studies remain to explore and understand the intricate network of cytokines 
and chemokines triggered or attenuated by the virus or host to beget a particular clinical outcome.
Materials and Methods
Subject recruitment, sample collection and disease status verification. This study was approved 
by and carried out under the guidelines of the Ethics Committee of the SingHealth Centralised Institutional 
Review Board (CIRB; CIRB reference number: 2012/448/E) for the recruitment from KK Women’s and Children’s 
Hospital, Singapore, as well as the Medical Ethics Committee (reference number: 872.7) and the Medical Research 
and Ethics Committee of the Ministry of Health, Malaysia (reference number: NMRR-12-1038-13816) for the 
recruitment from the University of Malaya Medical Center, Malaysia. Informed consent was obtained from the 
parents/guardians of all the recruited subjects.
In this study, the patients were evaluated by clinicians using a clinical case definition of fever, oral ulcers, and 
skin lesions on the palms and soles for HFMD. The clinically-defined HFMD cases were confirmed using at least 
one of the laboratory tests, including viral genotyping, virus isolation and genotyping, as well as anti-EV-A71 IgM 
antibody detection. Only laboratory-confirmed cases were included in this study. Serum samples from patients 
diagnosed with HFMD and healthy volunteers were collected for cytokine and chemokine profiling.
Human Cytokine and Chemokine Bio-Plex Assays. The patient and healthy sera were assayed using the 
Bio-Plex ProTM human cytokine 21-plex assay kit (Bio-Rad #MF0005KMII) and Bio-Plex ProTM human cytokine 
27-plex assay kit (Bio-Rad #M500KCAF0Y) according to the manufacturer’s instructions. The raw data was pro-
cessed using Bio-Plex Manager software version 6.1 (Bio-Rad Laboratories, USA). Cytokines with out-of-range 
(OOR) readings that were below its detection limits were recorded as 0.1 pg/ml for subsequent statistical analyses 
which involved log transformation of data.
Statistical Analyses. All statistical analyses were performed using GraphPad Prism version 4.0 (GraphPad 
software, USA), using Mann-Whitney or Kruskal-Wallis non-parametric tests (without Gaussian distribution 
assumption). Kruskal-Wallis non-parametric tests were coupled with Dunns post-test to compare all pairs of 
groups. All p-values were automatically adjusted by the program to account for false discovery rates associated with 
multiple comparisons. (Appropriately-adjusted) p-values below 0.05 were considered to be statistically significant.
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